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Introduction
In 2021, approximately 600,000 people will perish 
to cancer, and of those, 50,000 will be solely 
pancreatic cancer. Pancreatic ductal 
adenocarcinoma (PDAC) makes up 90% of all
pancreatic cancer cases and is often diagnosed 
late stage due to its asymptomatic nature, causing 
the patient to have fewer options, most commonly 
leading to death, making it one of the deadliest 
forms of cancer. Currently, there are no diagnostic 
or imaging tools for early detection and this project 
intents to address this knowledge gap.
Experimental Methods
Genetically engineered mice (GEM), models (P48Cre: 
LSLKrasG12D; LSL-p53R172H (KPC)) with pre-invasive 
pancreatic intraepithelial neoplasia (PanIN) precursor lesions 
and control mice (P48:Cre or WT C57BL/6) without pancreatic 
lesions metabolic process were analyzed using hyperpolarized 
1- 13C pyruvate magnetic resonance spectroscopy (MRS). The 
dissolution dynamic nuclear polarization (DNP) operating at 3T 
was utilized to hyperpolarize 1-13C pyruvate. The 13C MRS of 
hyperpolarized 1- 13C pyruvate were acquired at a 7T Bruker 
MRI scanner. 
The biochemical development of alanine transaminase (ALT) 
and lactate dehydrogenase (LDH) enzyme activity were 
assessed. Afterward, deep learning (DL) techniques were 
implemented to develop a model and reveal hybrid biomarkers 
from the MRI and metabolic imaging to predict early detection of 
pancreatic cancer. The model was developed through Bayesian 
DL techniques and multi-modal data integration to allow 
uncertainty measurements and learn features from imaging 
modalities to consider improving prediction accuracy. After 
training the model, the learned features from multiple modalities 
to identify any correlation between MRI and metabolic imaging 
are explored that may lead to the discovery of new hybrid 
biomarkers with predictive values for the early detection.
Conclusion
Findings from this emerging combination of DL and hyperpolarization-MRS techniques could potentially be translated into clinics for 
detection of pancreatic premalignant lesion in high-risk populations through early screenings with Figure 4 demonstrating the entire 
process more visually. Current efforts are ongoing to translate this technology at High-Risk Pancreatic Cancer (HR-PC) clinic at MD 
Anderson Cancer Center. 
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LDH = Lactate Dehydrogenase
ALT = Alanine Aminotransferase
An early-stage biomarker of biomarker of 
pancreatic cancer is the conversion of 
hyperpolarized (HP) pyruvate to lactate and 
alanine.
Results 
Hyperpolarized alanine-to-lactate signal ratio was 
found to decrease through progression from low to 
high-grade PanINs. These results demonstrate that 
there are significant alterations of ALT and LDH 
activities through the transformation from early to 
advanced PanINs lesions. Furthermore, we 
demonstrated that real-time conversion can be used 
as metabolic imaging biomarkers of pancreatic 
premalignant lesions, and the appropriate DL 
combining feature from the MRI and metabolic 
imaging as complementary modalities can lead to 
proper prediction of early detection in this KPC GEM 
model.
We are capable of monitoring this metabolic 
conversion rate employing hyperpolarized 
metabolic imaging. Employing hyperpolarized 
magnetic resonance (HP-MR) in unison with 
Artificial Intelligence (AI) to detect earlier 
premalignant stages of PDAC and even predict 
the efficacy of therapy in order to maximize 
treatment efficacy. HP-MR allows us to view the 











The live metabolic imaging 
is best displayed through 
MR spectroscopy (MRS) in 
which you can see real-
time metabolic conversion. 
Through Deep learning (DL)
applied to the AI, we can 
swiftly screen this data in 
order to catch a pre-





The real-time 13C MR spectra were acquired in vivo 
following injection of hyperpolarized pyruvate. The lactate 
production was significantly higher in advanced time 
points. The mice were imaged at three different timepoints. 
Figure 4
A visual representation of the experimental method and outcome.
